CClinicalTrials.gg
Not yet recruitingNCT07650669Wearables-HFUpdated Sep 28, 2026

Wearable Technology in Heart Failure Patients

An observational study in Heart Failure, sponsored by The Cleveland Clinic. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2026-09-28.

Sponsored by The Cleveland Clinic · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
500
Ages
18 Years to 85 Years
Sex
All
01

Study summary

The primary objective is to establish a Cleveland Clinic-led registry designed to integrate continuous physiological data from consumer wearables, captured by the HeartBit app and a Case Western Reserve University (CWRU)-based platform, with clinical data from patients' individual Electronic Health Record (EHR). This proposal is for understanding the use of personal wearable devices (such as: Fitbit, and Apple Watch) to gather physiological data (such as: heart-rate, steps taken, sleep cycles, and calories expended) and correlate those data with self-reported health status. The research team intends to collect all of the data generated by the participant's personal wearable devices and to perform an integrated analysis of the physiological data generated by the wearable devices. The investigators specifically aim to uncover patterns from the data that they can evolve models from. The investigators' goal is to better predict and diagnose the adverse effects associated with daily lifestyle, including cardiovascular risk, musculoskeletal, metabolic risks, stress, and sleep disturbances. These data may be used to better understand the daily habits and lifestyle choices to possibly predict a person's health and disease risk to provide a more comprehensive diagnosis with early recognition and prevention. As wearable devices become more accurate and cheaper to purchase for the general public, integrative analysis of wearable data from multiple devices may lead to models that can be used by clinicians and basic scientists to make inferences about the daily lifestyle and its effects on health and disease.

02

Conditions studied

  • Heart Failure

Browse trials for

Keywords

  • Heart Failure
  • Wearable Device
  • FitBit
  • Garmin
  • Apple Watch
03

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

This prospective, observational registry will enroll adult participants, aged 18 to 85 years, who have been diagnosed with heart failure or are identified as being at risk of developing heart failure. The study aims to enroll an indefinite number of participants at Cleveland Clinic.

Inclusion criteria

  • Participants must be between 18 and 85 years of age.
  • Participants must have a diagnosis of heart failure or be identified as at risk of developing heart failure.
  • Participants must either own or be willing to acquire a compatible personal consumer-grade wearable device (such as Fitbit and Apple Watch) and must enroll via the HeartBit app.

Exclusion criteria

Exclusion Criteria:

  • Individuals presenting with cognitive impairments or mental incapacity that would impede their understanding of, or cooperation with, the study protocol.
04

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
500 participants (estimated)
Target follow-up
2 Years
Patient registry
Yes
05

What researchers measure

Primary outcomes

  1. Establish Wearables Registry

    To establish a Cleveland Clinic-led registry that integrates continuous physiological data from consumer wearables, captured by the HeartBit app and a Case Western Reserve University-based platform, with comprehensive clinical and laboratory data from the Cleveland Clinic EHR.

    Time frame: 10 years

Secondary outcomes

  1. Association between Wearable-derived Heart Rate and Clinical Outcomes

    To determine whether, and to what extent, changes in wearable-derived heart rate are associated with clinical outcomes, including hospitalizations, emergency department visits, and changes in laboratory markers.

    Time frame: 10 years

  2. Association between Wearable-derived Physical Activity and Clinical Outcomes

    To determine whether, and to what extent, changes in wearable-derived physical activity are associated with clinical outcomes, including hospitalizations, emergency department visits, and changes in laboratory markers.

    Time frame: 10 years

  3. Association between Wearable-derived Sleep Metrics and Clinical Outcomes

    To determine whether, and to what extent, changes in wearable-derived sleep metrics are associated with clinical outcomes, including hospitalizations, emergency department visits, and changes in laboratory markers.

    Time frame: 10 years

06

Study locations

1 site
  • Cleveland Clinic
    Cleveland, Ohio 44195, United States
    • Valesha Province, MS · Contact · provinv@ccf.org · 216-636-6153
    • Jeniffer Wilcox · Contact · kirsopj@ccf.org · 216-636-6153
    • W. H. Wilson Tang, MD · Principal investigator
07

Registry details

Key details

Study ID
NCT07650669
Lead sponsor
The Cleveland Clinic
Collaborators
Case Western Reserve University
Responsible party
Wilson Tang (Staff, HBKR, Cleveland Clinic Research & Staff, Heart Failure, Cardiovascular Medicine, The Cleveland Clinic) — Principal investigator
First posted
Jun 16, 2026
Start date
Jan 2027 (estimated)
Primary completion
Jun 2037 (estimated)
Completion
Jun 2040 (estimated)
Last update
Sep 28, 2026

Study contacts

Valesha Province, MS
Contact
provinv@ccf.org
216-636-6153
Jennifer Wilcox
Contact
kirsopj@ccf.org
216-636-6153

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion